Почетна › Sitnoćelijski rak pluća › Florida
Kliničke studije za Sitnoćelijski rak pluća u državi Florida
39 studija za Sitnoćelijski rak pluća traži učesnike na lokacijama u državi Florida.
Gradovi u državi Florida
- Orlando14 студија
- Tampa10 студија
- Miami10 студија
- Plantation5 студија
- Coral Springs4 студија
- Sarasota3 студија
- Cape Coral3 студија
- Jacksonville3 студија
- St. Petersburg3 студија
- Deltona3 студија
Zvanični tekst studije (na engleskom)
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Miami Cancer Institute, Miami
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07488676BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
- Total Health and Research Center, Miami
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07625644DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers
- H. Lee Moffitt Cancer Center and Research Institute, Tampa
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07707895A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
- Florida Cancer Specialists - South, Fort Myers
- Mid Florida Hematology and Oncology Center, Orange City
- Florida Cancer Specialists - North, St. Petersburg
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT06646276A Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Cell Lung Cancer (Dareon®-Rosetta35)
- University of Miami, Miami
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07843940DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
- Bioresearch Partner - Hialeah Hospital, Hialeah
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07472517A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
- GSK Investigational Site, Hialeah
- GSK Investigational Site, Miami
- GSK Investigational Site, Plantation
- и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07099898A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC
- Cancer Specialists of North Florida, Jacksonville
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT07459634A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- AdventHealth Cancer Institute, Orlando
Тражи се учесникФаза 1
Узраст 19 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT06586957VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Holy Cross Hospital (site 213), Fort Lauderdale
- Memorial Cancer Institute at Memorial Healthcare Systems (site 132), Pembroke Pines
Тражи се учесникФаза 1/2
Узраст од 18 до 80 · Оба пола · Ажурирано 4. 11. 2026. · NCT03556228A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
- University of Florida College of Medicine /ID# 277496, Gainesville
- Ocala Oncology Center /ID# 278269, Ocala
- Moffitt Cancer Center /ID# 277573, Tampa
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 27. 10. 2026. · NCT07155174Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
- Moffitt Cancer Center, Tampa
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT07278479A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 118, Celebration
- Research Site 127, Margate
- Research Site 137, Orlando
- и још 2
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT05914116AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Avenzo Therapeutics Recruiting Site, Orlando
- Avenzo Therapeutics Recruiting Site, Sarasota
- Avenzo Therapeutics Recruiting Site, Tampa
Тражи се учесникФаза 1/2
Узраст од 18 до 75 · Оба пола · Ажурирано 16. 10. 2026. · NCT07038343A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
- Clermont Oncology Center, Clermont
- Mid Florida Hematology and Oncology Center, Orange City
- Cancer Centers of Bevard, Rockledge
- и још 4
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 16. 10. 2026. · NCT07218146Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- Cancer Care Centers of Brevard, Inc, Palm Bay
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT06712355Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
- BRCR Coral Springs, Coral Springs
- Mid Florida Hematology and Oncology Center, Orange City
- BRCR Global - Tamarac, Tamarac
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07226999A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
- University of Miami Hospital and Clinics, Sylvester Cancer Center ( Site 1111), Miami
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT06780137AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
- Florida Cancer Specialists and Research Institute, Sarasota
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 5. 10. 2026. · NCT07454642The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
- Advent Health, Orlando
- Florida Cancer Specialists South, Port Charlotte
Тражи се учесникФаза 1/2
Узраст 12 и старији · Оба пола · Ажурирано 2. 10. 2026. · NCT04585750DESTINY-PANTUMOUR04
- Research Site, Coral Springs
- Research Site, St. Petersburg
- Research Site, West Palm Beach
Тражи се учесникОпсервациона студија
Узраст од 18 до 130 · Оба пола · Ажурирано 25. 9. 2026. · NCT07124000Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- MDR Core Network, Boynton Beach
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 24. 9. 2026. · NCT06047379A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Florida Cancer Specialists & Research Institute - South /ID# 281387, Fort Myers
- Orlando Health Cancer Institute /ID# 280418, Orlando
- Moffitt Cancer Center /ID# 279732, Tampa
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 23. 9. 2026. · NCT07365241Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Sylvester Comprehensive Cancer Center, Miami
- Sara Cannon Research Institute Lake Nona, Orlando
- Hematology - Oncology Associates of the Treasure Coast, Port Saint Lucie
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 21. 9. 2026. · NCT05983432Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
- University of Florida Health Cancer Center at Orlando Health, Orlando
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 17. 9. 2026. · NCT07778316A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
- Site 1009, Plantation
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 17. 9. 2026. · NCT07407933Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
- University of Miami, Miami
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 28. 8. 2026. · NCT07057791Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
- Florida Cancer Specialists, Fort Myers
Тражи се учесникФаза 1/2
Узраст од 18 до 100 · Оба пола · Ажурирано 27. 8. 2026. · NCT06726148A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
- Mayo Clinic in Florida, Jacksonville
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 26. 8. 2026. · NCT06892548Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
- Moffitt Cancer Center, Tampa
Тражи се учесникФаза 1
Узраст од 18 до 99 · Оба пола · Ажурирано 21. 8. 2026. · NCT07531095A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
- Clermont Oncology Center, Clermont
- The Oncology Institute of Hope and Innovation, Fort Lauderdale
- Moffitt Cancer Center, Tampa
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 17. 8. 2026. · NCT06095505A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- AdventHealth Celebration, Celebration
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 11. 8. 2026. · NCT05592626A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- University of Miami Hospital and Clinics Sylvester Comprehensive Cancer Center, Miami
- AdventHealth Orlando, Cancer Institute, Orlando
- H. Lee Moffitt Cancer Center and Research Institute, Inc, Tampa
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 6. 8. 2026. · NCT06203210DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
- Mayo Clinic Cancer Center, Jacksonville
- University of Miami, Miami
- H. Lee Moffitt Cancer Center and Research Institute, Tampa
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 23. 7. 2026. · NCT05882058A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Florida Cancer Specialists, Orlando
- Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 22. 7. 2026. · NCT06131840A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
- Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 9. 7. 2026. · NCT07174583Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
- BRCR Global, Plantation
- Florida Clinical Trials Group, Plantation
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 7. 4. 2026. · NCT07424547Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- Florida Cancer Specialists-Lake Nona, Orlando
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 18. 2. 2026. · NCT07030257A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer
- Zelgen Site 102, Plantation
Тражи се учесникФаза 1
Узраст од 18 до 75 · Оба пола · Ажурирано 6. 8. 2025. · NCT06592638Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.